NPCE

NeuroPace Inc

NasdaqAdd to watchlist

Energy,Healthcare · Medical Devices

$14.41

+$0.28+1.98%

Delayed · 2026-08-28T20:00:00.000Z · marketstack

1 open-market sale on file ($399K), none of them under a pre-arranged plan. Who, and when

Aug 24, 2026$14.41

+$0.42+3.00%over 1M

Session

Day range82% of range

$13.76$14.55

Fundamentals

Visualize fundamentals and more

Market cap: 491.44M
P/E ratio: -

Risk factors, year on year

Item 1AMar 2026 10-KMar 2025

added: 54
dropped: 62
re-drafted: 52

Out of 294 passages in this year’s Item 1A.

New this year

• our ability to continue to maintain a commercially viable manufacturing process at our manufacturing facility that is compliant with current Good Manufacturing Practices and QMSR;

115 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

FDA approval
Litigation
Data privacy
Reimbursement
Cybersecurity
Product recalls
Debt covenants
Key people

And 14 more.

FDA approval
Obtaining the necessary FDA or international approvals or other qualifications under applicable regulatory requirements and ensuring non-infringement of third-party intellectual property or other proprietary rights could result in a significant interruption …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Aug 28, 2026 · the last close

NeuroPace Inc investor relations

What NPCE has filed with the SEC. This is not NeuroPace Inc’s own investor relations site: these filings are the primary source that site publishes from.

Companies like NeuroPace Inc

Also filed under Medical Devices, ranked by how closely they sit beside NPCE.

BSXBoston Scientific Corp.compare with NPCE
MDTMedtronic plccompare with NPCE
ABTAbbott Laboratories

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

FDA approval
Litigation
Data privacy
Reimbursement
Cybersecurity
Product recalls
Debt covenants
Key people

And 14 more.

FDA approval
Obtaining the necessary FDA or international approvals or other qualifications under applicable regulatory requirements and ensuring non-infringement of third-party intellectual property or other proprietary rights could result in a significant interruption …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

EWEdwards Lifesciences Corpcompare with NPCE

Ask about NeuroPace Inc

The assistant answers from what NPCE has actually filed: 6 annual reports filed with the SEC, 39 Form 4 filings from the last year and 2 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from NPCE's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of NeuroPace Inc each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with NeuroPace Inc

Be told the moment a NPCE insider trades
Put NeuroPace Inc on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
NeuroPace Inc's income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about NeuroPace Inc's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

13 more events are on Measure

Free, no card, and it does not expire. See what the paid plans add

Risk factors, year on year

Item 1AMar 2026 10-KMar 2025

added: 54
dropped: 62
re-drafted: 52

Out of 294 passages in this year’s Item 1A.

New this year

• our ability to continue to maintain a commercially viable manufacturing process at our manufacturing facility that is compliant with current Good Manufacturing Practices and QMSR;

115 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add